Literature DB >> 2023731

Glaucoma-like discs with subsequent increased ocular pressures.

B Schwartz1, G Tomita, T Takamoto.   

Abstract

Four patients with glaucoma-like discs, normal visual fields, and normal ocular pressures (less than 21 mmHg), first detected by direct ophthalmoscopy, were followed without treatment. Increased ocular pressures (greater than or equal to 21 mmHg) subsequently developed in these patients at an average of 8.1 years after the recognition of their glaucoma-like discs. Before the increased ocular pressure developed, two patients showed retinal nerve fiber layer loss and one showed optic disc hemorrhages. There are two possible hypotheses to explain this sequence of events. The first is that the optic discs and nerve fiber layer defects were produced by abnormal diurnal levels of ocular pressures or levels of ocular pressure, although less than 21 mmHg, which may be abnormal for the optic disc. The second hypothesis is that there are two independent events, one producing abnormalities in the optic disc and nerve fiber layer and a second producing the increased ocular pressure.

Entities:  

Mesh:

Year:  1991        PMID: 2023731     DOI: 10.1016/s0161-6420(91)32344-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

1.  Evaluation and definition of physiologic macro cups with confocal optic nerve analysis (HRT).

Authors:  E Arenas-Archila; F Caycedo-Yunis; M R Rodríguez
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

2.  Are large optic nerve heads susceptible to glaucomatous damage at normal intraocular pressure? A three-dimensional study by laser scanning tomography.

Authors:  R O Burk; K Rohrschneider; H Noack; H E Völcker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Tyrosine triple mutated AAV2-BDNF gene therapy in an inner retinal injury model induced by intravitreal injection of N-methyl-D-aspartate (NMDA).

Authors:  Asaka Lee Shiozawa; Tsutomu Igarashi; Maika Kobayashi; Kenji Nakamoto; Shuhei Kameya; Shigeto Fujishita; Hiroshi Takahashi; Takashi Okada
Journal:  Mol Vis       Date:  2020-06-03       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.